Carl joined our company in 2009. His previous experience includes various commercial and leadership roles within Pfizer as well as strategic and analytical roles within the Boston Consulting Group.
"We simply cannot sit still for a minute. Too many clinicians lack confidence in their diagnostic decision and too many people are still seeking answers to their symptoms – whether they have ADHD or not. We have the technology and we are on an endless quest to evolve, to make our technology available to all."
We are in proud partnership with Verdane to accelerate growth in ADHD through new technologies, new customer segments, and significant expansion in existing markets.
Having the support of an experienced investor in healthcare software has helped us deliver ground-breaking, innovative technologies that improve care, reduce healthcare costs, and provide a unique experience for ADHD patients and their families.
